⚖
Compare Funds
See how two funds stack up side by side, real returns, risk, cost and portfolio overlap.
VS
Key Metrics Comparison
| Metric | Kotak Healthcare Fund - Regular Plan - Growth | HDFC Pharma and Healthcare Fund - Growth - Direct Plan |
|---|---|---|
| Snapshot | ||
| AMC | Kotak MF | HDFC MF |
| Category | Equity - Sectoral Fund - Pharma & Health Care | Equity - Sectoral Fund - Pharma & Health Care |
| NAV | ₹16.55 (29 Oct 2026) | ₹21.95 (30 Oct 2026) |
| Rating | ★★★ | ★★★★★ |
| Benchmark | Nifty Healthcare Index - TRI | BSE Health Care - TRI |
| Fund Manager | Dhananjay Tikariha | Nikhil Mathur |
| Inception | 11 Dec 2023 | 04 Oct 2023 |
| Returns | ||
| 1Y | 20.15% | 22.64% |
| 3Y | — | 30.41% |
| 5Y | — | — |
| Since Inception | 19.07% | 29.15% |
| Risk | ||
| 14.85 | 14.07 | |
| 0.99 | 0.59 | |
| 0.91 | 1.59 | |
| 2.19 | 21.67 | |
| 1.86 | 3.48 | |
| -11.13% | -9.23% | |
| Costs | ||
| Expense Ratio | 2.56% | 1.03% |
| Exit Load | 0.50% on or before 30D, Nil after 30D | 1% on or before 30D, Nil after 30D |
| Min SIP | ₹100 | ₹100 |
| Min Lumpsum | ₹100 | ₹100 |
| Lock-in | None | None |
Min SIP is reported per fund, not per plan, every plan of a fund shares the same figure.
Portfolio Overlap
Kotak MF61%
HDFC MF61%
38.7%Only 38.7% of holdings by weight are common between Kotak MF and HDFC MF, based on each fund's top 20 disclosed holdings, not the full portfolio.
Common holdingKotak MFHDFC MF
Divi's Laboratories Ltd.9.35%9.39%
Sun Pharmaceutical Industries Ltd.13.21%8.28%
Torrent Pharmaceuticals Ltd.4.65%3.65%
Max Healthcare Institute Ltd.3.61%3.61%
Cipla Ltd.3.26%4.15%
Acutaas Chemicals Ltd.4.17%3.18%
Apollo Hospitals Enterprise Ltd.2.97%3.69%
Anthem Biosciences Ltd.2.34%3.17%
Krishna Institute of Medical Sciences Ltd2.71%2.10%
Category context: Equity vs Equity. Open the full Screener →